Literature DB >> 3986082

Nicotine pharmacokinetics and its application to intake from smoking.

C Feyerabend, R M Ings, M A Russel.   

Abstract

Five subjects were given 25 micrograms/kg nicotine intravenously over 1 min, before and after a loading period involving the smoking of six cigarettes. Plasma nicotine concentrations declined in a biphasic manner, the half-lives of the initial and terminal phases averaging 9 min and 133 min respectively. Terminal half-lives before and after the loading period were essentially the same suggesting the absence of saturation kinetics at nicotine concentrations that build up during smoking. The plasma clearance of nicotine and the volume of distribution were very high averaging 915 ml/min and 1731, respectively. Two approaches were used to calculate the nicotine intake from smoking. The average dose of nicotine absorbed from one cigarette was 1.06 mg which was 82% of the standard machine-smoked yield of 1.3 mg. To illustrate their potential use in 'nicotine titration' studies, these approaches were used to compare nicotine intake from smoking a high (2.4 mg) and low (0.6 mg) nicotine cigarette. The dose of nicotine absorbed averaged 1.14 mg and 0.86 mg per cigarette respectively, being 48% and 143% of the machine-smoked yields.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986082      PMCID: PMC1463714          DOI: 10.1111/j.1365-2125.1985.tb02637.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Cigarette smoking and plasma levels of nicotine.

Authors:  P F Isaac; M J Rand
Journal:  Nature       Date:  1972-04-07       Impact factor: 49.962

2.  Assay of nicotine in biological materials: sources of contamination and their elimination.

Authors:  C Feyerabend; M A Russell
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

3.  Amount of nicotine and carbon monoxide inhaled by smokers of low-tar, low-nicotine cigarettes.

Authors:  R V Ebert; M E McNabb; K T McCusker; S L Snow
Journal:  JAMA       Date:  1983-11-25       Impact factor: 56.272

4.  Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.

Authors:  N L Benowitz; P Jacob; R T Jones; J Rosenberg
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

5.  Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites.

Authors:  G A Kyerematen; M D Damiano; B H Dvorchik; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-12       Impact factor: 6.875

6.  Absorption and metabolism of nicotine from cigarettes.

Authors:  A K Armitage; C T Dollery; C F George; T H Houseman; P J Lewis; D M Turner
Journal:  Br Med J       Date:  1975-11-08

7.  Nicotine chewing gum as a substitute for smoking.

Authors:  M A Russell; S R Sutton; C Feyerabend; P V Cole; Y Saloojee
Journal:  Br Med J       Date:  1977-04-23

8.  Disposition kinetics and effects of intravenous nicotine.

Authors:  J Rosenberg; N L Benowitz; P Jacob; K M Wilson
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

9.  Smokers of low-yield cigarettes do not consume less nicotine.

Authors:  N L Benowitz; S M Hall; R I Herning; P Jacob; R T Jones; A L Osman
Journal:  N Engl J Med       Date:  1983-07-21       Impact factor: 91.245

10.  Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.

Authors:  M A Russell; M Jarvis; R Iyer; C Feyerabend
Journal:  Br Med J       Date:  1980-04-05
View more
  33 in total

1.  Effect of ulcerative colitis and smoking on rectal blood flow.

Authors:  E D Srivastava; M A Russell; C Feyerabend; J Rhodes
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career.

Authors:  Alvin V Terry; Michael W Decker
Journal:  Biochem Pharmacol       Date:  2011-06-12       Impact factor: 5.858

Review 3.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

4.  Development of central and peripheral smoking effects over time.

Authors:  M Hasenfratz; R Nil; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse.

Authors:  A D Lê; Douglas Funk; Steven Lo; Kathleen Coen
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

6.  Substituted heteroaromatic compounds: effect on nicotine self-administration in rats.

Authors:  John R Cashman; Karl Okolotowicz; Matt Cerny; Robert Johnson; Aaron Janowsky; Marc R Azar
Journal:  Psychopharmacology (Berl)       Date:  2012-01-05       Impact factor: 4.530

7.  The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

Authors:  Alvin V Terry; Jerry J Buccafusco; R Foster Schade; Leah Vandenhuerk; Patrick M Callahan; Wayne D Beck; Elizabeth J Hutchings; James M Chapman; Pei Li; Michael G Bartlett
Journal:  Biochem Pharmacol       Date:  2012-01-08       Impact factor: 5.858

8.  Comparison of measured and FTC-predicted nicotine uptake in smokers.

Authors:  G D Byrd; J H Robinson; W S Caldwell; J D deBethizy
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

9.  Increased cotinine elimination and cotinine-N-oxide formation by phenobarbital induction in rat and mouse.

Authors:  H Foth; J Aubrecht; M Höhne; U I Walther; G F Kahl
Journal:  Clin Investig       Date:  1992 Mar-Apr

10.  Carbon Nanotube Membranes for use in the Transdermal Treatment of Nicotine Addiction and Opioid Withdrawal Symptoms.

Authors:  Caroline L Strasinger; Nicole N Scheff; Ji Wu; Bruce J Hinds; Audra L Stinchcomb
Journal:  Subst Abuse       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.